Unani Treatment of Acne vulgaris

Efficacy of Unani formulation in Busoore Labaniya (Acne vulgaris): An open labelled single arm clinical study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024029

Enrollment

Registered

2020-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Paste of Murdar sang, Bora Armani, Roghan gul for local application : Murdar sang and Bora armani in equal quantity will be grinded into powder form and sieve through 100

Eligibility

Inclusion criteria

Inclusion criteria: 1- Patients of age group 14-40years, Both genders. 2- Clinically diagnosed patients of Acne vulgaris. 3- Patients/ Guardians who agree to sign the informed consent form and follow the protocol

Exclusion criteria

Exclusion criteria: 1- Patients who do not co-operate. 2- Age 40 years. 3- Patients having local wound and infection on face 4- Pregnant and lactating women. 5- Patient with systemic diseases like Diabetes Mellitus, hypertension. 6- Patients on corticosteroid therapy, anticonvulsant therapy, or taking OCP 7- Patient suffering from other concomitant disease like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema etc.

Design outcomes

Primary

Measure	Time frame
Improvement in Global Acne Severity Scale photographs Cardiff acne Disability index Timepoint: Weekly for 4 weeks	—

Secondary

Measure	Time frame
Improvement in QOL Erythema Dryness Peeling Burning ItchingTimepoint: Weekly for 4 weeks	—

Countries

India

Contacts

Public ContactSultana Anjum

National Institute Of Unani Medicine

drmuzaffar79@gmail.com9590366192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026